SEP
MRK icon

Signature Equity Partners’s Merck MRK Stock Holding History

Signature Equity Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
2,470
+1,640
+198% +$189K 0.16% 136
2025
Q4 		$87.3K Buy
+830
New +$77.9K 0.05% 298

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Signature Equity Partners's MRK Position: Q1 2026 in Review

Signature Equity Partners increased its Merck (MRK) stake by 198% in Q1 2026, buying an estimated $189K and bringing the position to 2,470 shares worth $297K. The position accounts for 0.16% of the portfolio, ranked #136.

Signature Equity Partners first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Signature Equity Partners held 2,470 shares of Merck worth $297K as of Q1 2026.
  • Signature Equity Partners bought 1,640 Merck shares in Q1 2026, an estimated $189K.
  • Merck made up 0.16% of Signature Equity Partners's portfolio in Q1 2026, its #136 holding.
  • Signature Equity Partners first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.